AMGEVITA®▼ (adalimumab) is subject to additional monitoring. This will allow quick identification of new safety information
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/
Side effects can also be reported to Amgen Limited on 01223 436441. By reporting side effects you can help provide more information on the safety of this medicine.
If you think there may be a defect or quality issue with the Amgen product you have received, please call us on 01223 436441 and provide us with the details. Please ensure that you keep your packaging, so we are able to identify your product more easily.